CP
CLEARPharma
ShopPre-OrdersSale
CP
CLEARPharma

Your source for pharmaceutical-grade performance compounds. Lab-tested, quality assured.

ClearPharmacy@proton.me

Shop

  • Shop All
  • On Sale
  • Pre-Orders
  • Wishlist

Support

  • Track Your Order
  • FAQ
  • Contact Us
  • Request a Product
  • Terms & Shipping Policy
  • Privacy

Trust & Learn

  • Fund Testing / COAs
  • Compound Education
  • Calculators & Tools
  • Blog

© 2026 Clear Pharma. All rights reserved.

Home
Shop
Cart
Wishlist
Account

Your Cart

Your cart is empty.

Browse products
All compounds

Trenbolone Acetate

Oils

Trenbolone Acetate is a potent 19-nortestosterone derivative widely considered the most powerful anabolic steroid available. With an anabolic rating of 500 and androgenic rating of 500 (5x testosterone on both axes), it delivers dramatic physique and performance changes but carries a significantly harsher side effect profile than most other compounds.

Half-life: 1-2 daysDose: 150-200mg/week (beginner/first tren run), 200-400mg/week (intermediate), 400-700mg/week (advanced - not recommended)PCT Required

Notes

Trenbolone is NOT a beginner compound under any circumstances. It should only be considered by experienced users who have completed multiple testosterone cycles and at least one cycle with a milder 19-nor (like nandrolone). Trenbolone Acetate is preferred over Enanthate for first-time tren users because the short ester allows rapid clearance if side effects become intolerable. Always run with a testosterone base. Start LOW (150-200mg/week) to assess tolerance. Many experienced users find 200-300mg/week is the sweet spot for risk-reward. Cardiovascular health monitoring is essential.

Trenbolone binds to the androgen receptor with approximately 3-5x the affinity of testosterone, producing extraordinarily potent anabolic and androgenic effects. It does NOT aromatize to estrogen due to structural modifications, but it does bind to progesterone receptors (contributing to progestogenic gynecomastia risk). Trenbolone powerfully upregulates IGF-1 production in muscle tissue and the liver. It exhibits strong anti-glucocorticoid activity by competing with cortisol for glucocorticoid receptor binding, reducing muscle catabolism. Its nutrient partitioning effect is mediated through enhanced insulin sensitivity in muscle tissue while simultaneously promoting lipolysis in adipose tissue. Trenbolone also increases nitrogen retention and protein synthesis to a degree unmatched by any other commercial AAS.

Trenbolone Acetate is rapidly absorbed from the injection depot, reaching peak blood levels within 12-24 hours. The short acetate ester (2-carbon chain) results in a half-life of approximately 1-2 days, necessitating frequent injection. The compound is metabolized primarily in the liver, with oxidized metabolites (which give urine a characteristic dark amber/brown color) excreted renally. Trenbolone and its metabolites can be detected in urine for 4-5 months. Due to the short half-life, blood levels drop rapidly upon cessation, and the compound substantially clears within 5-7 days of the last injection.

Typical Dose

150-200mg/week (beginner/first tren run), 200-400mg/week (intermediate), 400-700mg/week (advanced - not recommended)

Frequency

Every other day (EOD) or every day (ED) for stable blood levels

Administration

Intramuscular injection

Half-Life

1-2 days

  • ✓Extreme increases in strength and lean muscle mass
  • ✓Potent nutrient partitioning effect (shuttles calories toward muscle, away from fat)
  • ✓Does not aromatize to estrogen
  • ✓Dramatic improvement in muscle hardness, density, and vascularity
  • ✓Significant fat loss even in a caloric surplus due to metabolic enhancement
  • ✓Powerful anti-catabolic properties during caloric deficit
  • ✓Enhanced feed efficiency (more muscle per calorie consumed)
  • ✓Rapid and dramatic visual physique changes
  • ⚠Severe insomnia and sleep disturbance (tren insomnia)
  • ⚠Profuse night sweats and increased body temperature
  • ⚠Significant cardiovascular strain (dramatic negative impact on lipids)
  • ⚠Severe HPTA suppression
  • ⚠"Tren cough" - acute bronchospasm immediately after injection (from oil entering bloodstream)
  • ⚠Elevated prolactin leading to potential gynecomastia and sexual dysfunction
  • ⚠Significant increase in aggression, irritability, anxiety, and paranoia ("tren rage/paranoia")
  • ⚠Severe reduction in cardiovascular endurance and aerobic capacity
  • ⚠Accelerated hair loss in predisposed individuals
  • ⚠Dark-colored urine from oxidized metabolites (trenbolone is nephrotoxic at higher doses)

Contraindications

  • 🚫Any pre-existing cardiovascular disease (absolute contraindication)
  • 🚫Hypertension
  • 🚫Liver disease or elevated liver enzymes
  • 🚫Kidney disease or impaired renal function
  • 🚫History of anxiety, depression, or psychiatric conditions
  • 🚫Sleep disorders
  • 🚫Prostate issues
  • 🚫Those with fewer than 3-4 prior AAS cycles of experience
  • 🚫Anyone prioritizing cardiovascular health or longevity
Total Testosterone (ensure adequate base)Estradiol (Sensitive - trenbolone can cross-react with non-sensitive E2 assays giving false high readings)Prolactin (critical - target under 20 ng/mL)Lipid Panel (HDL will be severely impacted, often dropping to single digits)Hematocrit and HemoglobinLiver enzymes (AST, ALT - will likely be elevated)Kidney function (BUN, Creatinine, eGFR)Fasting blood glucose and HbA1c (trenbolone can impair glucose tolerance)Blood pressure (monitor frequently)Cardiac biomarkers if cardiovascular symptoms present
Week 1: Compound kicks in fast. Increased aggression, body temperature, and night sweats may begin within 3-5 days. Strength increases noticeable. Sleep disturbances often start early. Week 2-3: Full effects emerging. Dramatic strength increases, visible muscle hardness, and early body composition changes. Side effects typically peak and stabilize. Assess tolerance at this point. Week 4-6: Peak anabolic effects. Physique changes are dramatic - increased vascularity, muscle density, and significant recomposition effect. Strength at all-time highs. Side effects are at their worst. Week 7-8: If running an 8-week cycle (recommended max for acetate), final push. Many users report diminishing marginal returns and increasing side effect burden beyond 8 weeks. Post-cycle: Discontinue trenbolone. Wait 4-5 days, then begin PCT. Mental side effects typically resolve within 1-2 weeks of cessation. Sleep quality improves rapidly.
PCT Required

Discontinue Trenbolone Acetate and wait 4-5 days before beginning PCT. If running with long-ester testosterone, switch to testosterone propionate for the final 2-3 weeks to synchronize clearance. PCT: Nolvadex 20mg/day for 6-8 weeks, or Clomid 50mg/day for 4 weeks then 25mg/day for 4 weeks. HCG during cycle is strongly recommended (500IU 2x/week). Some users bridge with hCG at 1000-1500IU EOD for 10-14 days before starting SERMs. Recovery from trenbolone is typically more difficult and prolonged than from testosterone alone. Multiple post-PCT blood panels are advisable.

  • 1.Start at 150-200mg/week for your first trenbolone experience regardless of experience level with other compounds
  • 2.ALWAYS use the acetate ester for your first tren run so sides clear quickly if intolerable
  • 3.Keep cabergoline on hand; dose at 0.25-0.5mg 2x/week only if prolactin symptoms appear or bloods confirm elevation
  • 4.Expect your cardio capacity to drop significantly; adjust training accordingly and do not neglect LISS cardio (20-30 min walks)
  • 5.If insomnia becomes severe, consider melatonin (3-5mg), magnesium glycinate, and keeping the bedroom cold
  • 6.Use the sensitive/LC-MS estradiol assay; standard immunoassay gives falsely elevated E2 readings with trenbolone in your system
Testosterone PropionateTestosterone CypionateMasteron (Drostanolone)Anavar (Oxandrolone)Winstrol (Stanozolol)
  1. [1]Yarrow JF, et al. 17beta-Hydroxyestra-4,9,11-trien-3-one (Trenbolone) exhibits tissue selective anabolic activity. J Steroid Biochem Mol Biol. 2010.
  2. [2]Donaldson IA, et al. Cardiovascular and metabolic effects of trenbolone. J Appl Physiol. 2009.
  3. [3]Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502-521.
  4. [4]Meyer HH, Rapp M. Reversible binding of the anabolic steroid trenbolone to bovine androgen receptors. Steroids. 1985.